- MedicalCV, Inc. (OTCBB:MCVI), www.medcvinc.com, announced today the completion of the 75th surgical case utilizing its laser-based technology platform, which includes both the ATRILAZE(TM) and SOLAR(TM) Surgical Ablation Systems.

(AHC Newsletters Via Thomson Dialog NewsEdge) Product pipeline Spectranetics PATENT study explores plaque removal above knee By OMAR FORD, CDU Staff Writer In-stent restenosis is a major issue when it comes to percutaneous coronary intervention of coronary vessels, often requiring patients to undergo repeat..

(AHC Newsletters Via Thomson Dialog NewsEdge) Product briefs Digital Health wins PMA for Retasure retinopathy detection By OMAR FORD, BB&T Staff Writer Annual visits to an optometrist's office aren't usually very a high on a diabetic patient's to-do list.

TORONTO, Nov. 9 /CNW/ - Fralex Therapeutics Inc. (TSX:FXI) ("Fralex" or the "Company"), a medical technology company developing neuromodulation therapy, announced today that David Chazanovitz has agreed to join the Board of Directors.

PMMedicalCV, Inc. (OTCBB:MCVI), www.medcvinc.com, announced that it has entered into a settlement agreement pursuant to which MedicalCV will pay J Giordano Securities Group $750,000 in cash.